Condition: Relapsed Mantle Cell Lymphoma · Refractory Mantle Cell Lymphoma · Sponsor: Fondazione Italiana Linfomi - ETS
This is a prospective, phase 2, multicenter, open-label, single-arm study. Primary objective is to assess the efficacy of loncastuximab tesirine given as consolidation therapy after salvage immunochemotherapy in BTKi (Bruton Tyrosine Kinase inhibitors) -treated (or BTKi intolerant) R/R (Relapse or Refractory) MCL (Mantle Cell Lymphoma) patients. The sponsor of this clinical trial is Fondazione Italiana Linfomi - ETS (FIL ETS).
This description comes directly from the study's public registry record.
Stefania Badiali · +39.059.9769912 · sbadiali@filinf.it
Giorgio Priolo · +39.0131.033175 · gpriolo@filinf.it
Always discuss trial participation with your own doctor first.
| ASST Spedali Civili di Brescia | Brescia, Italy, Italy | Recruiting |
| S.C. Ematologia - A.S.O. "SS Antonio e Biagio e Cesare Arrigo" | Alessandria, Italy | Recruiting |
| S.C. di Ematologia - A.O. S. Croce e Carle | Cuneo, Italy | Recruiting |
| Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi | Florence, Italy | Recruiting |
| Ematologia - Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia | Genova, Italy | Recruiting |
| Ematologia - Fondazione IRCCS Istituto Nazionale dei Tumori di Milano | Milan, Italy | Recruiting |
| S.C. Ematologia - ASST Grande Ospedale Metropolitano Niguarda | Milan, Italy | Recruiting |
| UOC Ematologia Oncologica - Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale | Naples, Italy | Recruiting |
| SCDU Ematologia - AOU Maggiore della Carità di Novara | Novara, Italy | Recruiting |
| Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello | Palermo, Italy | Recruiting |
| Divisione di Ematologia - IRCCS Policlinico S. Matteo di Pavia | Pavia, Italy | Recruiting |
| Ematologia - Ospedale delle Croci | Ravenna, Italy | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05249959